S
Shan Xiong
Researcher at Guangzhou Medical University
Publications - 39
Citations - 3873
Shan Xiong is an academic researcher from Guangzhou Medical University. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 6, co-authored 27 publications receiving 2390 citations.
Papers
More filters
Journal ArticleDOI
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.
Wei Jie Guan,Wenhua Liang,Yi Zhao,Heng Rui Liang,Zi Sheng Chen,Yimin Li,Xiaoqing Liu,Ru Chong Chen,Chun Li Tang,Tao Wang,Chun-Quan Ou,Li Li,Ping Yan Chen,Ling Sang,Wei Wang,Jianfu Li,Caichen Li,Li Min Ou,Bo Cheng,Shan Xiong,Zheng Yi Ni,Jie Xiang,Yu Hu,Lei Liu,Hong Shan,Chun Liang Lei,Yi Xiang Peng,Li Wei,Yong Liu,Ya Hua Hu,Peng Peng,Jian-ming Wang,Ji Yang Liu,Zhong Chen,Gang Li,Zhi Jian Zheng,Shao Qin Qiu,Jie Luo,Chang Jiang Ye,Shao Yong Zhu,Lin Ling Cheng,Feng Ye,Shi Yue Li,Jin Ping Zheng,Nuo Fu Zhang,Nanshan Zhong,Jianxing He +46 more
TL;DR: It is found that among laboratory confirmed cases of COVID-19, patients with any comorbidity yielded poorer clinical outcomes than those without and a greater number ofComorbidities also correlated with poorer clinical outcome.
Posted ContentDOI
Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis
Wei-jie Guan,Wenhua Liang,Yi Zhao,Hengrui Liang,Zisheng Chen,Yimin Li,Xiaoqing Liu,Ruchong Chen,Chun-Li Tang,Tao Wang,Chun-Quan Ou,Li Li,Ping-Yan Chen,Ling Sang,Wei Wang,Jianfu Li,Caichen Li,Limin Ou,Bo Cheng,Shan Xiong,Zhengyi Ni,Jie Xiang,Yu Hu,Lei Liu,Hong Shan,Chunliang Lei,Yi-xiang Peng,Li Wei,Yong Liu,Ya-hua Hu,Peng Peng,Jian-ming Wang,Ji-yang Liu,Zhong Chen,Gang Li,Zhi-jian Zheng,Shao-qin Qiu,Jie Luo,Chang-jiang Ye,Shao-yong Zhu,Linling Cheng,Feng Ye,Shiyue Li,Jinping Zheng,Nuofu Zhang,Nanshan Zhong,Jianxing He +46 more
TL;DR: Comorbidities are present in around one fourth of patients with COVID-19 in China, and predispose to poorer clinical outcomes, and have significantly escalated risks of reaching to the composite endpoint compared with those who had a single comorbidity.
Journal ArticleDOI
Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China.
Wenhua Liang,Wei Jie Guan,Caichen Li,Yimin Li,Heng Rui Liang,Yi Zhao,Xiaoqing Liu,Ling Sang,Ling Sang,Ru Chong Chen,Chun Li Tang,Tao Wang,Wei Wang,Qi Hua He,Zi Sheng Chen,Sook San Wong,Mark Zanin,Jun Liu,Xin Xu,Jun Huang,Jianfu Li,Li Min Ou,Bo Cheng,Shan Xiong,Zhan Hong Xie,Zheng Yi Ni,Yu Hu,Lei Liu,Hong Shan,Chun Liang Lei,Yi Xiang Peng,Li Wei,Yong Liu,Ya Hua Hu,Peng Peng,Jian-ming Wang,Ji Yang Liu,Zhong Chen,Gang Li,Zhi Jian Zheng,Shao Qin Qiu,Jie Luo,Chang Jiang Ye,Shao Yong Zhu,Lin Ling Cheng,Feng Ye,Shi Yue Li,Jin Ping Zheng,Nuo Fu Zhang,Nuo Fu Zhang,Nanshan Zhong,Jianxing He +51 more
TL;DR: There were more severe cases and poorer outcomes for COVID-19 patients treated in Hubei, which might be attributed to the prolonged duration of symptom onset to hospitalisation in the epicentre, and the reason for delaying hospitalisation is warranted.
Journal ArticleDOI
The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis.
Feng Li,Caichen Li,Xiuyu Cai,Zhanhong Xie,Liquan Zhou,Bo Cheng,Ran Zhong,Shan Xiong,Jianfu Li,Zhuxing Chen,Ziwen Yu,Jianxing He,Wenhua Liang +12 more
TL;DR: Wang et al. as discussed by the authors evaluated the role of CD8+ tumor infiltrating lymphocytes (TILs) in predicting efficacy and survival of various cancer patients treated with ICIs.
Journal ArticleDOI
Cancer Risks in Solid Organ Transplant Recipients: Results from a Comprehensive Analysis of 72 Cohort Studies.
Zhenyu Huo,Caichen Li,Xin Xu,Fan Ge,Runchen Wang,Yaokai Wen,Haoxin Peng,Xiangrong Wu,Hengrui Liang,Guilin Peng,Run Li,Danxia Huang,Ying Chen,Ran Zhong,Bo Cheng,Shan Xiong,Weiyi Lin,Jianxing He,Wenhua Liang +18 more
TL;DR: It is demonstrated thatSolid organ transplant recipients displayed a higher risk of some site-specific cancers, providing individualized guidance for clinicians to early detect, evaluate, and treat cancer among solid organ transplantation recipients.